HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert J Glynn Selected Research

bococizumab

1/2017Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.
1/2017Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.
8/2016Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert J Glynn Research Topics

Disease

51Myocardial Infarction
03/2024 - 01/2002
47Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 01/2003
33Inflammation (Inflammations)
02/2023 - 01/2003
31Stroke (Strokes)
03/2024 - 01/2002
27Type 2 Diabetes Mellitus (MODY)
03/2024 - 08/2013
26Neoplasms (Cancer)
03/2024 - 12/2002
22Heart Failure
03/2024 - 03/2002
21Hypertension (High Blood Pressure)
01/2024 - 01/2002
14Rheumatoid Arthritis
01/2023 - 09/2006
12Hemorrhage
11/2019 - 04/2003
12Unstable Angina
10/2018 - 02/2002
11Coronary Disease (Coronary Heart Disease)
03/2024 - 07/2002
11Macular Degeneration (Age-Related Maculopathy)
03/2024 - 03/2007
11Venous Thromboembolism
11/2022 - 04/2003
11Atrial Fibrillation
11/2022 - 07/2011
10Thrombosis (Thrombus)
01/2023 - 03/2008
9Atherosclerosis
01/2022 - 05/2005
8Frailty
11/2023 - 08/2005
7Cataract (Cataracts)
03/2024 - 03/2003
7Infections
12/2023 - 01/2017
7Hyperlipidemias (Hyperlipidemia)
01/2017 - 11/2008
6Glaucoma
01/2023 - 01/2007
5Dyslipidemias (Dyslipidemia)
03/2024 - 03/2010
5Chronic Renal Insufficiency
01/2024 - 08/2002
5Gout
01/2023 - 06/2015
5Breast Neoplasms (Breast Cancer)
01/2022 - 12/2002
5Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2020 - 04/2012
5Diabetes Mellitus
04/2016 - 03/2002
5Ischemic Stroke
01/2016 - 02/2006
4Insulin Resistance
03/2024 - 01/2016
4Anemia
01/2023 - 10/2011
4Diabetic Retinopathy (Retinopathy, Diabetic)
12/2018 - 12/2003
4Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 06/2006
4Arthritis (Polyarthritis)
12/2010 - 06/2006
3Acute Kidney Injury (Acute Renal Failure)
03/2024 - 01/2021
3Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
03/2024 - 01/2021
3Pain (Aches)
03/2024 - 12/2010
3Osteoarthritis
03/2024 - 08/2005
3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2024 - 07/2015
3Chronic Kidney Failure (Chronic Renal Failure)
01/2024 - 07/2002
3Skin Neoplasms (Skin Cancer)
01/2023 - 01/2019

Drug/Important Bio-Agent (IBA)

37Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2024 - 01/2007
37C-Reactive ProteinIBA
01/2023 - 07/2003
21LipidsIBA
01/2024 - 08/2003
21Rosuvastatin Calcium (Crestor)FDA Link
01/2016 - 11/2008
18LDL CholesterolIBA
11/2022 - 07/2003
16CholesterolIBA
01/2023 - 07/2003
15Biomarkers (Surrogate Marker)IBA
03/2024 - 05/2005
14Vitamin EFDA LinkGeneric
01/2022 - 03/2006
13canakinumabFDA Link
01/2023 - 01/2017
12Glucose (Dextrose)FDA LinkGeneric
03/2024 - 08/2012
12Methotrexate (Mexate)FDA LinkGeneric
01/2024 - 08/2013
11Warfarin (Coumadin)FDA LinkGeneric
11/2022 - 04/2003
11oxidized low density lipoproteinIBA
01/2022 - 03/2010
8Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2017 - 05/2002
8VitaminsIBA
01/2016 - 11/2007
7Lipoproteins (Lipoprotein)IBA
03/2024 - 04/2012
7SodiumIBA
12/2022 - 01/2021
7Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2020 - 05/2002
7DabigatranFDA Link
11/2019 - 01/2016
7Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2016 - 12/2003
7Antihypertensive Agents (Antihypertensives)IBA
05/2013 - 01/2002
6Opioid Analgesics (Opioids)IBA
03/2024 - 12/2010
6InterleukinsIBA
01/2024 - 10/2017
6Glucagon-Like Peptide-1 Receptor AgonistsIBA
11/2023 - 01/2018
6Interleukin-6 (Interleukin 6)IBA
01/2022 - 10/2017
6Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2022 - 11/2008
5empagliflozinIBA
03/2024 - 01/2022
5omega-Chloroacetophenone (Mace)IBA
03/2024 - 10/2018
5Sodium-Glucose Transporter 2 InhibitorsIBA
11/2023 - 01/2018
5HDL CholesterolIBA
11/2022 - 07/2010
5Triglycerides (Triacylglycerol)IBA
11/2022 - 05/2005
5AnticoagulantsIBA
11/2022 - 01/2018
5Monoclonal AntibodiesIBA
01/2019 - 01/2017
5LDL Lipoproteins (beta Lipoproteins)IBA
01/2016 - 11/2008
5Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2011 - 03/2002
4Vitamin DFDA LinkGeneric
12/2023 - 01/2017
4Dipeptidyl-Peptidase IV InhibitorsIBA
11/2023 - 11/2015
4Sodium-Glucose Transport ProteinsIBA
11/2023 - 01/2018
4Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2023 - 12/2021
4Uric Acid (Urate)IBA
01/2023 - 06/2015
4Antirheumatic Agents (DMARD)IBA
01/2023 - 09/2006
4Estrogens (Estrogen)FDA Link
01/2022 - 05/2005
4Hemoglobins (Hemoglobin)IBA
11/2020 - 10/2011
4Antipsychotic Agents (Antipsychotics)IBA
01/2018 - 12/2002
4Fibrinogen (Factor I)FDA Link
04/2016 - 03/2007
4Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
04/2016 - 05/2007
4beta Carotene (Betacarotene)FDA Link
11/2007 - 03/2003
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2024 - 09/2006
3Clopidogrel (Plavix)FDA Link
11/2023 - 10/2013
3sorbinilIBA
10/2023 - 12/2003
3Retinaldehyde (Retinal)IBA
01/2023 - 01/2022
3Metformin (Glucophage)FDA LinkGeneric
12/2022 - 01/2021
3HDL LipoproteinsIBA
11/2022 - 01/2016

Therapy/Procedure

48Therapeutics
10/2023 - 01/2002
4Surgical Amputation (Amputations)
03/2024 - 01/2020
4Home Nursing (Nursing, Home)
01/2022 - 07/2004
4Secondary Prevention
01/2020 - 08/2013
4Coronary Artery Bypass (Coronary Artery Bypass Surgery)
09/2013 - 01/2002
3Aftercare (After-Treatment)
01/2024 - 10/2018